Urgo Medical Overview
Pro stress-test →Urgo Medical focuses on advanced wound care within the healthcare sector, offering evidence-based treatments and support services to healthcare professionals for the healing of patients' wounds. The company has crossed the €1 billion revenue threshold as a 100% family-owned enterprise with no debt.
Strategic Profile
Pro stress-test →The family group attributes its exceptional growth to two key drivers: international development and innovation. Urgo Medical's advanced wound-healing product division represents approximately 50% of consolidated revenue and is the primary export growth engine, with the US as the top market in a global advanced wound care market estimated at €2 billion.
Competitive Landscape
Pro stress-test →Urgo competes in the advanced wound care market against multinational medical device manufacturers. Primary competitors include Mölnlycke Health Care, Smith & Nephew, and Lohmann & Rauscher. Urgo differentiates through French manufacturing heritage, evidence-based product innovation, and family-business stability positioning it as a challenger to larger, publicly-traded rivals.
Industry Context
Urgo Medical operates in Medical Devices / Wound Care.
Key facts
Founded: 1958 · Headquarters: Chenôve, France · Employees: 1,100+ (Urgo Healthcare division); ~1,200 total Dijon workforce · Revenue: €1.01B (2025) · Market cap: N/A